^T Tanaka, T Nakata, T Oka, T Ogawa, F Okamoto, Y Kusaka, K Sohmiya, K Shimamoto, K Itakura (2001). “Defect in human myocardial long-chain fatty acid uptake is caused by FAT/CD36 mutations”. Journal of Lipid Research42 (5): 751-759. PMID11352982.
^K Fukuchi, S Nozaki, T Yoshizumi, S Hasegawa, T Uehara, T Nakagawa, T Kobayashi, Y Tomiyama, S Yamashita, Y Matsuzawa, T Nishimura (1999). “Enhanced myocardial glucose use in patients with a deficiency in long-chain fatty acid transport (CD36 deficiency)”. Journal of Nuclear Medicine40 (2): 239-43. PMID10025829.
^N Yamamoto, N Akamatsu, H Sakuraba, H Yamazaki, K Tanoue (1994). “Platelet glycoprotein IV (CD36) deficiency is associated with the absence (type I) or the presence (type II) of glycoprotein IV on monocytes”. Blood83 (2): 392-397. PMID7506948.
^B R Curtis, R H Aster (1996). “Incidence of the Nak(a)-negative platelet phenotype in African Americans is similar to that of Asians”. Transfusion36 (4): 331-334. doi:10.1046/j.1537-2995.1996.36496226147.x. PMID8623134.
^H Yanai , H Chiba, H Fujiwara, M Morimoto, K Abe, S Yoshida, Y Takahashi, H Fuda, S P Hui, H Akita, K Kobayashi, K Matsuno (2000). “Phenotype-genotype correlation in CD36 deficiency types I and II”. Journal of Thrombosis and Haemostasis84 (3): 436-441. PMID11019968.
^Takao Tanaka, Tatsuji Kono, Fumio Terasaki, Taigo Kintaka, Koichi Sohmiya, Takayuki Mishima, Yasushi Kitaura (2003). “Gene-environment interactions in wet beriberi: effects of thiamine depletion in CD36-defect rats”. American Journal of Physiology-Heart and Circulatory Physiology285 (4): H1546-53. doi:10.1152/ajpheart.00182.2003. PMID12969879.